Axplora to further expand Farmabios

Axplora is to invest a further €35 million to expand its Farmabios site in Gropello Cairoli, Italy. This will add 6,200 m2 of space, more than doubling the total to 108,000. It comes on top of €45 million already spent between 2020 and 2024, during which time the workforce roughly doubled to around 300. 

A key feature is the RS40 building for the handling of HPAPIs, whose layout is based on exposure zoning for strict segregation of high-potency operations within dedicated suites. The facility supports OELs down to 10 ng/m3 and complies fully with OEB5 containment criteria. Its design incorporates stand-alone workshops and fully isolated process rooms to mitigate cross-contamination risks.

There is also a new micronisation department, whose rooms are equipped with isolators specifically designed for HPAPI processing, plus expanded warehouse capacity. Farmabios also has specialised facilities for cytotoxic and sterile processing.

“The new greenfield expansion is designed to support the next generation of pharmaceutical manufacturing – with built-in flexibility, increased production efficiency, and full alignment with global regulatory standards,” the company stated.